Search This Blog

Thursday, October 31, 2019

Abiomed EPS beats by $0.10, misses on revenue

Abiomed (NASDAQ:ABMD): Q2 Non-GAAP EPS of $1.03 beats by $0.10; GAAP EPS of $0.28.
Revenue of $204.97M (+12.8% Y/Y) misses by $1.48M.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)